JY
OGEN icon

Jeff Yass’s Oragenics OGEN Stock Holding History

Jeff Yass’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-343
Closed -$14.8K – 12887
2024
Q1 		$14.8K Buy
+343
New +$33.8K ﹤0.01% 11868
2023
Q1 		– Sell
-82
Closed -$15.4K – 13206
2022
Q4 		$15.4K Buy
+82
New +$28.9K ﹤0.01% 11843
2022
Q3 		– Sell
-14
Closed -$9K – 13854
2022
Q2 		$9K Sell
14
-28
-67% -$16.2K ﹤0.01% 12531
2022
Q1 		$26K Buy
42
+3
+8% +$2.2K ﹤0.01% 12547
2021
Q4 		$31K Buy
+39
New +$39.5K ﹤0.01% 12733
2020
Q2 		– Sell
-21
Closed -$22K – 10677
2020
Q1 		$22K Buy
21
+8
+62% +$7.69K ﹤0.01% 9915
2019
Q4 		$13K Buy
+13
New +$11.6K ﹤0.01% 9530
2019
Q3 		– Sell
-10
Closed -$9K – 10636
2019
Q2 		$9K Buy
+10
New +$9.18K ﹤0.01% 10085
2017
Q1 		– Sell
-1
Closed -$9K – 9660
2016
Q4 		$9K Buy
+1
New +$9.28K ﹤0.01% 9476

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
LWM
Lionsbridge Wealth Management Jacksonville Beach, Florida $102M AUM 28.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jeff Yass's OGEN Position: Q2 2024 in Review

Jeff Yass sold out of Oragenics (OGEN) in Q2 2024, closing a stake of 343 shares — an estimated $14.8K sold.

Jeff Yass first reported a position in OGEN in Q4 2016 and held it in 9 quarters. The position peaked at $31K in Q4 2021. 13 funds tracked by Wall St. Rank hold OGEN as of Q2 2024.

  • Jeff Yass reported no remaining Oragenics position as of Q2 2024 after selling out during the quarter.
  • Jeff Yass sold 343 Oragenics shares in Q2 2024, an estimated $14.8K.
  • Jeff Yass first reported a position in Oragenics in Q4 2016 and held it in 9 quarters.
  • Jeff Yass's Oragenics position peaked at $31K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Oragenics as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.